Page last updated: 2024-11-12

galavit

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sodium luminolate: an antioxidant; MP1032 a phase-pure anhydrous polymorph of 5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15480750
MeSH IDM0499345

Synonyms (33)

Synonym
AKOS006343693
3-aminophthalhydrazide monosodium salt
luminol sodium
HY-15922A
luminol (sodium salt)
MP-1032 ,
5-amino-2,3-dihydro-1,4-*phthalazinedione sodium
AC-33249
AKOS025312526
mfcd00161491
W15451
luminol sodium salt, vetec(tm) reagent grade, 98%
luminolsodium
134459-06-6
sodium 5-amino-1,4-dioxo-3,4-dihydro-1h-phthalazin-2-ide
luminol monosodium salt
AS-13891
BCP13343
SY074060
luminolmono sodium salt
BP-27871
tamerit
3-aminophthalic hydrazide sodium
sodium luminolate
o-aminophthaloyl hydrazide sodium
unii-kfg2pzr7ux
5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt
o-aminophthalylhydrazide sodium
galavit
kfg2pzr7ux ,
3-aminophthalhydrazidemonosodiumsalt
luminol sodium [who-dd]
luminol monosodium
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's8 (72.73)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.76 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index75.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (42.86%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (57.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]